跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 180 条关于
“Orbimed”
全部
180
临床试验
87
药物
9
机构
3
资讯
81
去年
Myriad Genetics Secures $200 Million Credit Facility from OrbiMed to Fuel Growth Strategy
2个月前
Enliven Therapeutics Advances ELVN-001 Toward Pivotal Phase 3 Trial in CML Amid Strong Financial Position
去年
ProVerum Raises $80 Million Series B to Commercialize Minimally Invasive BPH Treatment
去年
Portuguese Startup Mondego Bio Secures Series A Funding to Develop Novel PTPN2 Inhibitors for Cancer Immunotherapy
去年
Minghui Pharmaceutical Secures $131 Million Pre-IPO Funding to Advance Oncology Pipeline and Commercial Launch
5个月前
Pinnacle Medicines Raises $89 Million Series B to Advance Oral Peptide Therapeutics into Clinical Trials
去年
Brenig Therapeutics Appoints New Leadership and Expands Parkinson's Disease Pipeline with NLRP3 Inhibitor Acquisition
8个月前
AirNexis Therapeutics Secures $200M Series A to Advance Dual PDE3/4 Inhibitor for COPD Treatment
5个月前
Sidewinder Therapeutics Raises $137M Series B to Advance Next-Generation Bispecific ADCs for Cancer Treatment
去年
Epigenic Therapeutics Secures $60 Million Series B to Advance Epigenetic Therapies for Hepatitis B and Cholesterol
第 1 页,共 9 页
上一页
下一页